Repaglinide
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Mukoviszidose Institut gGmbH
Overview
Repaglinide is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Repaglinide clinical trials
Explore related
Medical disclaimer. This page summarizes research about Repaglinide for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.